Ruggeri RM - Search Results

1

Nanostructures: between natural environment and medical practice.

Trovato MC, Andronico D, Sciacchitano S, Ruggeri RM, Picerno I, Di Pietro A, Visalli G. Trovato MC, et al. Among authors: ruggeri rm. Rev Environ Health. 2018 Sep 25;33(3):295-307. doi: 10.1515/reveh-2017-0036. Rev Environ Health. 2018. PMID: 30205650 Free article. Review. No abstract available.

2

Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.

Ruggeri RM, Villari D, Simone A, Scarfi R, Attard M, Orlandi F, Barresi G, Trimarchi F, Trovato M, Benvenga S. Ruggeri RM, et al. J Endocrinol Invest. 2002 Dec;25(11):959-66. doi: 10.1007/BF03344068. J Endocrinol Invest. 2002. PMID: 12553555

3

Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas.

Trovato M, Grosso M, Vitarelli E, Ruggeri RM, Alesci S, Trimarchi F, Barresi G, Benvenga S. Trovato M, et al. Among authors: ruggeri rm. Histol Histopathol. 2003 Apr;18(2):393-9. doi: 10.14670/HH-18.393. Histol Histopathol. 2003. PMID: 12647789

4

Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions.

Trovato M, Ulivieri A, Dominici R, Ruggeri RM, Vitarelli E, Benvenga S, Barresi G, Trimarchi F, Brunetti E, Vecchione A, Andreoli M, Sciacchitano S. Trovato M, et al. Among authors: ruggeri rm. Endocr Relat Cancer. 2004 Jun;11(2):365-76. doi: 10.1677/erc.0.0110365. Endocr Relat Cancer. 2004. PMID: 15163311

5

Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases.

Ruggeri RM, Barresi G, Sciacchitano S, Trimarchi F, Benvenga S, Trovato M. Ruggeri RM, et al. Histol Histopathol. 2006 Mar;21(3):249-56. doi: 10.14670/HH-21.249. Histol Histopathol. 2006. PMID: 16372246

6

Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas.

Ruggeri RM, Sciacchitano S, Vitarelli E, Trimarchi F, Barresi G, Trovato M. Ruggeri RM, et al. Arch Pathol Lab Med. 2006 Jul;130(7):1014-9. doi: 10.5858/2006-130-1014-IOMPAC. Arch Pathol Lab Med. 2006. PMID: 16831027 Free article.

7

Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions.

Ruggeri RM, Sciacchitano S, Trimarchi F, Barresi G, Trovato M. Ruggeri RM, et al. Eur J Histochem. 2007 Jul-Sep;51(3):193-8. Eur J Histochem. 2007. PMID: 17921114

8

Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals.

Ruggeri RM, Sciacchitano S, Vitale A, Cardelli P, Galletti M, Vitarelli E, Barresi G, Benvenga S, Trimarchi F, Trovato M. Ruggeri RM, et al. J Endocrinol Invest. 2009 May;32(5):465-9. doi: 10.1007/BF03346487. Epub 2009 Mar 25. J Endocrinol Invest. 2009. PMID: 19468262

9

What is New on Thyroid Cancer Biomarkers.

Ruggeri RM, Campennì A, Baldari S, Trimarchi F, Trovato M. Ruggeri RM, et al. Biomark Insights. 2008 Apr 29;3:237-252. doi: 10.4137/bmi.s669. Biomark Insights. 2008. PMID: 19578508 Free PMC article.

10

The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization.

Ruggeri RM, Vitarelli E, Barresi G, Trimarchi F, Benvenga S, Trovato M. Ruggeri RM, et al. Eur J Histochem. 2010 Jun 3;54(2):e24. doi: 10.4081/ejh.2010.e24. Eur J Histochem. 2010. PMID: 20558345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page